Contact the BPC-157 TB-500 digest

What we can help with

This is the contact point for the editorial team behind the BPC-157 TB-500 digest. We welcome corrections to the research summaries, questions about a specific citation, and feedback on coverage. If a study has been superseded, a finding has been mischaracterized, or a reference link has broken, tell us and we will fix it — accuracy against the source is the whole point of the project.

We are especially glad to hear from researchers and clinicians who can flag where the record has moved. The peptide literature changes, and a digest is only as good as its last review of the sources; pointers to newer systematic reviews or trial registrations are always useful, as is any correction to how a study's species, dose, or route has been described here.

Use the form below to reach the editors. Please include the page and, where relevant, the reference number you are writing about, so we can check the claim against its source quickly.

What we cannot do

We cannot give medical advice, and we cannot help anyone obtain BPC-157, TB-500, or the blend. We are not a clinic, not a prescriber, and not a vendor — no products are sold here and none are referred. Questions about diagnosis, treatment, or personal use should go to a qualified healthcare professional who can evaluate an individual case in person and take responsibility for the advice given.

We also cannot recommend a dose, a schedule, or a supplier, and we will not point anyone toward one. The dosage page reports only animal-study doses as research context, never human guidance, and the regulatory status of both peptides is summarized on the Wolverine legal status and FDA 503A category page from FDA's published positions. Beyond that, access questions fall outside what an editorial digest can or should answer — our remit begins and ends with the published record.